198 related articles for article (PubMed ID: 16432311)
1. Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation.
Fogelson AL; Tania N
Pathophysiol Haemost Thromb; 2005; 34(2-3):91-108. PubMed ID: 16432311
[TBL] [Abstract][Full Text] [Related]
2. Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.
Kuharsky AL; Fogelson AL
Biophys J; 2001 Mar; 80(3):1050-74. PubMed ID: 11222273
[TBL] [Abstract][Full Text] [Related]
3. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
Hoffman M; Monroe DM; Oliver JA; Roberts HR
Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway.
McVey JH
Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
[TBL] [Abstract][Full Text] [Related]
5. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
[TBL] [Abstract][Full Text] [Related]
6. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
7. Structure and biology of tissue factor pathway inhibitor.
Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
[TBL] [Abstract][Full Text] [Related]
8. [Interaction of blood and the vascular wall: hemostatic aspects].
Gerlach E; Becker BF
Z Kardiol; 1993; 82 Suppl 5():13-21. PubMed ID: 8154153
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.
Riewald M; Ruf W
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7742-7. PubMed ID: 11438726
[TBL] [Abstract][Full Text] [Related]
10. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
11. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
12. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Zhang E; St Charles R; Tulinsky A
J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI.
Miyazawa K; Fogelson AL; Leiderman K
Biophys J; 2023 Jan; 122(1):99-113. PubMed ID: 36403087
[TBL] [Abstract][Full Text] [Related]
14. [The role of tissue factor and its inhibitor in hemostasis].
Naumnik B; Małyszko J; Myśliwiec M
Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
[TBL] [Abstract][Full Text] [Related]
15. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
16. The regulation of clotting factors.
Kalafatis M; Egan JO; van 't Veer C; Cawthern KM; Mann KG
Crit Rev Eukaryot Gene Expr; 1997; 7(3):241-80. PubMed ID: 9399073
[TBL] [Abstract][Full Text] [Related]
17. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.
Thomassen S; Mastenbroek TG; Swieringa F; Winckers K; Feijge MAH; Schrijver R; Cosemans JMEM; Maroney SA; Mast AE; Hackeng TM; Heemskerk JWM
Thromb Haemost; 2018 Mar; 118(3):502-513. PubMed ID: 29452445
[TBL] [Abstract][Full Text] [Related]
18. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
Bajaj SP; Joist JH
Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
[TBL] [Abstract][Full Text] [Related]
19. Factor VIIa-mediated tenase function on activated platelets under flow.
Goel MS; Diamond SL
J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
[TBL] [Abstract][Full Text] [Related]
20. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
